HUB Investment Partners’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.12K Sell
3,000
-2,000
-40% -$5.97K ﹤0.01% 1378
2026
Q1
$15.4K Buy
5,000
+1,000
+25% +$4.25K ﹤0.01% 1136
2025
Q4
$14.4K Buy
+4,000
New +$17.4K ﹤0.01% 953

Other funds holding ALT

HUB Investment Partners's ALT Position: Q2 2026 in Review

HUB Investment Partners increased its Altimmune (ALT) stake by 0.33% in Q2 2026, buying an estimated $302 and bringing the position to 30,319 shares worth $92.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1288.

HUB Investment Partners first reported a position in ALT in Q4 2025 and has held it in 3 quarters since. The position peaked at $93.1K in Q1 2026. 39 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • HUB Investment Partners held 30,319 shares of Altimmune worth $92.2K as of Q2 2026.
  • HUB Investment Partners bought 101 Altimmune shares in Q2 2026, an estimated $302.
  • Altimmune made up ﹤0.01% of HUB Investment Partners's portfolio in Q2 2026, its #1288 holding.
  • HUB Investment Partners first reported a position in Altimmune in Q4 2025 and has held it in 3 quarters since.
  • HUB Investment Partners's Altimmune position peaked at $93.1K in Q1 2026.
  • 39 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on HUB Investment Partners's 13F filing for Q2 2026, filed 31 Jul 2026.